Adenosine A2A receptors and brain injury

Broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation

Jiang Fan Chen, Patricia K. Sonsalla, Felicita Pedata, Alessia Melani, Maria Rosaria Domenici, Patrizia Popoli, Jonathan Geiger, Luísa V. Lopes, Alexandre de Mendonça

Research output: Contribution to journalReview article

184 Citations (Scopus)

Abstract

This review summarizes recent developments that have contributed to understand how adenosine receptors, particularly A2A receptors, modulate brain injury in various animal models of neurological disorders, including Parkinson's disease (PD), stroke, Huntington's disease (HD), multiple sclerosis, Alzheimer's disease (AD) and HIV-associated dementia. It is clear that extracellular adenosine acting at adenosine receptors influences the functional outcome in a broad spectrum of brain injuries, indicating that A2ARs may modulate some general cellular processes to affect neuronal cells death. Pharmacological, neurochemical and molecular/genetic approaches to the complex actions of A2A receptors in different cellular elements suggest that A2A receptor activation can be detrimental or protective after brain insults, depending on the nature of brain injury and associated pathological conditions. An interesting concept that emerges from these studies is A2AR's ability to fine tune neuronal and glial functions to produce neuroprotective effects. While the data presented here clearly highlight the complexity of using adenosinergic agents therapeutically in PD and other neurodegenerative disorders and point out many areas for further inquiry, they also confirm that adenosine receptor ligands, particularly A2A receptor ligands, have many promising characteristics that encourage the pursuit of their therapeutic potential.

Original languageEnglish (US)
Pages (from-to)310-331
Number of pages22
JournalProgress in Neurobiology
Volume83
Issue number5
DOIs
StatePublished - Dec 1 2007

Fingerprint

Adenosine A2A Receptors
Brain Injuries
Purinergic P1 Receptors
Parkinson Disease
AIDS Dementia Complex
Ligands
Aptitude
Huntington Disease
Neuroprotective Agents
Nervous System Diseases
Neuroglia
Neurodegenerative Diseases
Adenosine
Multiple Sclerosis
Molecular Biology
Alzheimer Disease
Cell Death
Animal Models
Stroke
Pharmacology

Keywords

  • Adenosine A receptors
  • Adenosine receptor
  • Caffeine
  • HIV-1-associated dementia
  • Huntington's disease
  • Ischemia
  • Multiple sclerosis
  • Neuroprotection
  • Parkinson's disease
  • Purinergic receptors
  • Stroke

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Chen, J. F., Sonsalla, P. K., Pedata, F., Melani, A., Domenici, M. R., Popoli, P., ... de Mendonça, A. (2007). Adenosine A2A receptors and brain injury: Broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation. Progress in Neurobiology, 83(5), 310-331. https://doi.org/10.1016/j.pneurobio.2007.09.002

Adenosine A2A receptors and brain injury : Broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation. / Chen, Jiang Fan; Sonsalla, Patricia K.; Pedata, Felicita; Melani, Alessia; Domenici, Maria Rosaria; Popoli, Patrizia; Geiger, Jonathan; Lopes, Luísa V.; de Mendonça, Alexandre.

In: Progress in Neurobiology, Vol. 83, No. 5, 01.12.2007, p. 310-331.

Research output: Contribution to journalReview article

Chen, JF, Sonsalla, PK, Pedata, F, Melani, A, Domenici, MR, Popoli, P, Geiger, J, Lopes, LV & de Mendonça, A 2007, 'Adenosine A2A receptors and brain injury: Broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation', Progress in Neurobiology, vol. 83, no. 5, pp. 310-331. https://doi.org/10.1016/j.pneurobio.2007.09.002
Chen, Jiang Fan ; Sonsalla, Patricia K. ; Pedata, Felicita ; Melani, Alessia ; Domenici, Maria Rosaria ; Popoli, Patrizia ; Geiger, Jonathan ; Lopes, Luísa V. ; de Mendonça, Alexandre. / Adenosine A2A receptors and brain injury : Broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation. In: Progress in Neurobiology. 2007 ; Vol. 83, No. 5. pp. 310-331.
@article{4518790bc17e4df188f75cc000ecbcfd,
title = "Adenosine A2A receptors and brain injury: Broad spectrum of neuroprotection, multifaceted actions and {"}fine tuning{"} modulation",
abstract = "This review summarizes recent developments that have contributed to understand how adenosine receptors, particularly A2A receptors, modulate brain injury in various animal models of neurological disorders, including Parkinson's disease (PD), stroke, Huntington's disease (HD), multiple sclerosis, Alzheimer's disease (AD) and HIV-associated dementia. It is clear that extracellular adenosine acting at adenosine receptors influences the functional outcome in a broad spectrum of brain injuries, indicating that A2ARs may modulate some general cellular processes to affect neuronal cells death. Pharmacological, neurochemical and molecular/genetic approaches to the complex actions of A2A receptors in different cellular elements suggest that A2A receptor activation can be detrimental or protective after brain insults, depending on the nature of brain injury and associated pathological conditions. An interesting concept that emerges from these studies is A2AR's ability to fine tune neuronal and glial functions to produce neuroprotective effects. While the data presented here clearly highlight the complexity of using adenosinergic agents therapeutically in PD and other neurodegenerative disorders and point out many areas for further inquiry, they also confirm that adenosine receptor ligands, particularly A2A receptor ligands, have many promising characteristics that encourage the pursuit of their therapeutic potential.",
keywords = "Adenosine A receptors, Adenosine receptor, Caffeine, HIV-1-associated dementia, Huntington's disease, Ischemia, Multiple sclerosis, Neuroprotection, Parkinson's disease, Purinergic receptors, Stroke",
author = "Chen, {Jiang Fan} and Sonsalla, {Patricia K.} and Felicita Pedata and Alessia Melani and Domenici, {Maria Rosaria} and Patrizia Popoli and Jonathan Geiger and Lopes, {Lu{\'i}sa V.} and {de Mendon{\cc}a}, Alexandre",
year = "2007",
month = "12",
day = "1",
doi = "10.1016/j.pneurobio.2007.09.002",
language = "English (US)",
volume = "83",
pages = "310--331",
journal = "Progress in Neurobiology",
issn = "0301-0082",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Adenosine A2A receptors and brain injury

T2 - Broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation

AU - Chen, Jiang Fan

AU - Sonsalla, Patricia K.

AU - Pedata, Felicita

AU - Melani, Alessia

AU - Domenici, Maria Rosaria

AU - Popoli, Patrizia

AU - Geiger, Jonathan

AU - Lopes, Luísa V.

AU - de Mendonça, Alexandre

PY - 2007/12/1

Y1 - 2007/12/1

N2 - This review summarizes recent developments that have contributed to understand how adenosine receptors, particularly A2A receptors, modulate brain injury in various animal models of neurological disorders, including Parkinson's disease (PD), stroke, Huntington's disease (HD), multiple sclerosis, Alzheimer's disease (AD) and HIV-associated dementia. It is clear that extracellular adenosine acting at adenosine receptors influences the functional outcome in a broad spectrum of brain injuries, indicating that A2ARs may modulate some general cellular processes to affect neuronal cells death. Pharmacological, neurochemical and molecular/genetic approaches to the complex actions of A2A receptors in different cellular elements suggest that A2A receptor activation can be detrimental or protective after brain insults, depending on the nature of brain injury and associated pathological conditions. An interesting concept that emerges from these studies is A2AR's ability to fine tune neuronal and glial functions to produce neuroprotective effects. While the data presented here clearly highlight the complexity of using adenosinergic agents therapeutically in PD and other neurodegenerative disorders and point out many areas for further inquiry, they also confirm that adenosine receptor ligands, particularly A2A receptor ligands, have many promising characteristics that encourage the pursuit of their therapeutic potential.

AB - This review summarizes recent developments that have contributed to understand how adenosine receptors, particularly A2A receptors, modulate brain injury in various animal models of neurological disorders, including Parkinson's disease (PD), stroke, Huntington's disease (HD), multiple sclerosis, Alzheimer's disease (AD) and HIV-associated dementia. It is clear that extracellular adenosine acting at adenosine receptors influences the functional outcome in a broad spectrum of brain injuries, indicating that A2ARs may modulate some general cellular processes to affect neuronal cells death. Pharmacological, neurochemical and molecular/genetic approaches to the complex actions of A2A receptors in different cellular elements suggest that A2A receptor activation can be detrimental or protective after brain insults, depending on the nature of brain injury and associated pathological conditions. An interesting concept that emerges from these studies is A2AR's ability to fine tune neuronal and glial functions to produce neuroprotective effects. While the data presented here clearly highlight the complexity of using adenosinergic agents therapeutically in PD and other neurodegenerative disorders and point out many areas for further inquiry, they also confirm that adenosine receptor ligands, particularly A2A receptor ligands, have many promising characteristics that encourage the pursuit of their therapeutic potential.

KW - Adenosine A receptors

KW - Adenosine receptor

KW - Caffeine

KW - HIV-1-associated dementia

KW - Huntington's disease

KW - Ischemia

KW - Multiple sclerosis

KW - Neuroprotection

KW - Parkinson's disease

KW - Purinergic receptors

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=36249032646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36249032646&partnerID=8YFLogxK

U2 - 10.1016/j.pneurobio.2007.09.002

DO - 10.1016/j.pneurobio.2007.09.002

M3 - Review article

VL - 83

SP - 310

EP - 331

JO - Progress in Neurobiology

JF - Progress in Neurobiology

SN - 0301-0082

IS - 5

ER -